Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Bulletin Du Cancer|November 13, 2022
5-fluorouracil with oxaliplatin and/or irinotecan for advanced sinonasal intestinal-type adenocarcinoma (ITAC)Victor Sarradin, Sarah Betrian, Léonor Chaltiel, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 19, 2020
Management of the irradiated N0-neck during salvage pharyngo-laryngeal surgeryPaul Mazerolle, Philippe Gorphe, Benjamin Vairel, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 9, 2024
Oncologic safety of autologous fat grafting in primary breast reconstruction after mastectomy for cancerAnne-Sophie Navarro, Donia Omalek, Léonor Chaltiel, et al.
Bulletin Du Cancer|December 10, 2017
[Nomograms in routine clinical practice: Methodology, interest and limitations]Thomas Filleron, Léonor Chaltiel, Eva Jouve, et al.
Diseases of the Colon and Rectum|November 8, 2021
Oncologic and Functional Outcomes of Pelvic Perineal Reconstruction by Perineal Colostomy and Malone Procedure After Abdominoperineal ResectionAnthony Marinho, Nicolas Zalay, Léonor Chaltiel, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|April 21, 2021
Functional and oncological outcomes of salvage transoral robotic surgery: a comparative studyPierre Gazda, Clément Gauche, Léonor Chaltiel, et al.
Melanoma Research|November 6, 2020
PD-1 inhibitors might limit the development of brain metastases in patients with advanced melanomaMarion Marcaillou, Clara Linder, Léonor Chaltiel, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 7, 2023
Population pharmacokinetic analysis reveals no impact of aprepitant on the pharmacokinetics of ifosfamide, 2-dechloroifosfamide, and 3-dechloroifosfamideThibaud Valentin, Marie Lambert, Léonor Chaltiel, et al.
Pageof 3